Kezar Life Sciences buy HC Wainwright
Start price
04.12.23
/
50%
€0.81
Target price
04.12.24
€18.42
Performance (%)
-28.57%
Price
25.07.24
€0.60
Summary
This prediction is currently active. The prediction for Kezar Life Sciences disappoints with a performance of -28.57%. This prediction currently runs until 04.12.24. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Kezar Life Sciences | 2.586% | 2.586% |
iShares Core DAX® | 1.280% | 1.320% |
iShares Nasdaq 100 | -2.457% | -5.192% |
iShares Nikkei 225® | -2.006% | -1.389% |
iShares S&P 500 | -0.662% | -1.884% |
Comments by HC_Wainwright for this prediction
In the thread Kezar Life Sciences diskutieren
Kezar Life Sciences, Inc. (NASDAQ: KZR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Ratings data for KZR provided by MarketBeat
Stopped prediction by HC_Wainwright for Kezar Life Sciences
Kezar Life Sciences
Start price
Target price
Perf. (%)
€0.71
10.05.24
10.05.24
€18.56
10.05.25
10.05.25
-12.68%
25.07.24
25.07.24
Kezar Life Sciences
Start price
Target price
Perf. (%)
€0.80
27.11.23
27.11.23
€18.27
27.11.24
27.11.24
-25.63%
25.07.24
25.07.24
Kezar Life Sciences
Start price
Target price
Perf. (%)
€0.89
12.10.23
12.10.23
€18.90
12.10.24
12.10.24
-30.34%
25.07.24
25.07.24
Kezar Life Sciences
Start price
Target price
Perf. (%)
€1.05
25.09.23
25.09.23
€18.82
25.09.24
25.09.24
-43.33%
25.07.24
25.07.24